Loading...
Posaconazole Therapeutic Drug Monitoring in Pediatrics and Young Adults with Cancer
BACKGROUND: Limited information exists regarding the use of posaconazole for treating systemic fungal infections in children, adolescent, and young adult patients with cancer. At St. Jude Children’s Research Hospital, the recommended posaconazole dose in patients less than 34 kg is 18–24 mg/kg daily...
Na minha lista:
| Udgivet i: | Ann Pharmacother |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4384822/ https://ncbi.nlm.nih.gov/pubmed/23737511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1345/aph.1R775 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|